Projects per year
Fingerprint
Dive into the research topics where Natarajan Muthusamy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
Shen, B. (PI), Rader, C. (CoPI), Shen, B. B. (CoPI), Rader, C. (CoPI) & Muthusamy, N. (CoPI)
12/15/16 → 12/31/26
Project: Research
-
Validation of Siglec-6 as a novel target for cancer immunotherapy
Rader, C. (PI) & Muthusamy, N. (CoPI)
08/1/18 → 07/31/20
Project: Research
-
Phosphatase activation as therapeutic strategy for Chronic lymphocyic leukemia
Muthusamy, N. (PI) & Phelps, A. M. (CoPI)
09/25/15 → 08/31/21
Project: Research
-
Novel Immunotherapies for Lymphoid Malignancies
Byrd, J. C. (PI) & Muthusamy, N. (CoPI)
07/20/12 → 04/30/15
Project: Research
-
Validation of microRNAs as therapeutic targets in hematological malignancies
Muthusamy, N. (CoPI), Chan, K.K.-H. (CoPI) & Marcucci, G. (CoPI)
03/1/11 → 02/28/17
Project: Research
-
CD37 in acute myeloid leukemia: a novel surface target for drug delivery
Jeremy, E., Artiga, E., Elgamal, S., Cheney, C., Eicher, D., Zalponik, K., Orwick, S., Mao, C., Wasmuth, R., Harrington, B., Mustonen, A., Beshay, P., Halley, P., Castro, C., Williams, K., Hing, Z., Chen, T., Lucas, C., Vantangoli, N. J. & Lapalombella, R. & 7 others, , Jan 14 2025, In: Blood Advances. 9, 1, p. 1-14 14 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Second Generation Tiancimycin-Based Antibody–Drug Conjugates Enabled by Highly Efficient Semi-synthetic Approach Specifically Targeting B-Cell Malignancies
Kiefer, A. F., Thirugnanasambantham, P., Jin, Y., Steele, A. D., Hwang, D., Jiang, Y., Adhikari, A., Yang, D., Chang, J., Tafesse, R., Rader, C., Muthusamy, N. & Shen, B., Jul 28 2025, In: JACS Au. 5, 7, p. 3171-3181 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment
Wang, L., Leach, V., Muthusamy, N., Byrd, J. & Long, M., Jan 23 2024, In: Blood Advances. 8, 2, p. 470-481 12 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia
Nunes, J., Tafesse, R., Mao, C., Purcell, M., Mo, X., Zhang, L., Long, M., Cyr, M. G., Rader, C. & Muthusamy, N., Dec 2024, In: Nature Communications. 15, 1, 5180.Research output: Contribution to journal › Article › peer-review
Open Access11 Link opens in a new tab Scopus citations -
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
Chan, W. K., Williams, J., Sorathia, K., Pray, B., Abusaleh, K., Bian, Z., Sharma, A., Hout, I., Nishat, S., Hanel, W., Sloan, S. L., Yasin, A., Denlinger, N., Zhang, X., Muthusamy, N., Vasu, S., de Lima, M., Yang, Y., Baiocchi, R. & Alinari, L., Dec 2023, In: Experimental Hematology and Oncology. 12, 1, 79.Research output: Contribution to journal › Article › peer-review
Open Access17 Link opens in a new tab Scopus citations